Clinical Trial to evaluate efficacy and eafety of Lenabasumin for the diffuse dutaneous systemic sclerosis, a disease of the immune system attacking the connective tissue under the skin and around internal organs and blood vessels causing scarring and thickening of the tissue in these areas. Clinical Trial to evaluate efficacy and eafety of Lenabasuminfor the diffuse dutaneous systemic scl ...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasumin Diffuse Cutaneous Systemic Sclerosis - A Phase 3 safety and efficacy study of Lenabasumin Systemic Sclerosis A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and S ...
Product Name: Lenabasum5mgPowderinCapsule Product Code: [JBT-101] INN or Proposed INN: lenabasum Other descriptive name: resunab, ajulemic acid, anabasum Product Name: Lenabasum 20 mg PowderinCapsule Product Code: [JBT-101] Other descriptive name: resunab, ajulemic acid, anabasum Product Name: Lenabasum5mgPowderinCapsule Product Code: [JBT-101] INN or Proposed INN: lenabasum Ot ...
CORBUS PHARMACEUTICALS, INC
NULL
Not Recruiting
Female: yes Male: yes
354
Phase 3
United States;Spain;Israel;United Kingdom;Italy;Switzerland;France;Canada;Poland;Australia;Germany;Netherlands;Japan;Korea, Republic of United States;Spain;Israel;United Kingdom;Italy;Switzerland;France;Canada;Poland;Australia;Germany;N ...